Dss, Inc. bought $310 of IBO
owner at IMPACT BIOMEDICAL INC.. 200 shares at an average of $1.55, traded Mar 20, 2025, filed Mar 24, 2025.
Score components
- +12Role10% owner
- 0Trade size$310 at market
- -5Relative to holdingsUnder 1% of holdings (0.4%)
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -88.2%, 3m -55.3%, 6m -81.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001641172-25-000403, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 2, 2024 | SOpen-market sale Common Stockindirect: By Sentinel Brokers Company, Inc. | -20 | $2.90 | $58 | 53,080 | Mar 24, 2025 |
| Mar 20, 2025 | POpen-market purchase Common Stockindirect: By Sentinel Brokers Company, Inc. | +200 | $1.55 | $310 | 53,280 | Mar 24, 2025 |
| Mar 20, 2025 | SOpen-market sale Common Stockindirect: By Sentinel Brokers Company, Inc. | -53,280 | $4.68 | $249k | 0 | Mar 24, 2025 |
Related signals
Other insiders at IMPACT BIOMEDICAL INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | IBOsell IMPACT BIOMEDICAL INC. | Dss, Inc. owner | $1,686 906 shares | -0% | |
| 40Moderate | IMPACT BIOMEDICAL INC. | Todd D Macko Chief Financial Officer | $25k 45,000 shares | -23% | |
| 34Weak | IMPACT BIOMEDICAL INC. | Jason Grady director | $33k 50,000 shares | -17% | |
| 26Weak | IBOsell IMPACT BIOMEDICAL INC. | Dss, Inc. owner | $88k 161,000 shares | -23% | |
| 41Moderate | IBOsell IMPACT BIOMEDICAL INC. | Dss, Inc. owner | $88k 161,000 shares | -100% | |
| 54Moderate | IMPACT BIOMEDICAL INC. | Heng Fai Ambrose Chan director | $174k 351,555 shares | -100% | |
| 63Notable | IMPACT BIOMEDICAL INC. | Dss, Inc. owner | $845k 890,800 shares | -85% | |
| 68Notable | IMPACT BIOMEDICAL INC. | Heng Fai Ambrose Chan director, owner | $1.1M 1,689,693 shares | -198% | |
| 68Notable | IMPACT BIOMEDICAL INC. | Heng Fai Ambrose Chan director, owner | $2.9M 2,526,918 shares | -163% | |
| 65Notable | IMPACT BIOMEDICAL INC. | Dss, Inc. owner | $2.0M 605,620 shares | -364% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.